UGR
  |
> >
None
(Ref. CTS-109)
04
julio
2025
julio 2025
<- ->
L M X J V S D
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

Producción científica


Buscar por:

Lista

Publicación
A. Agil Abdalla "Vitamin A status in acute exacerbations of cystic fibrosis",  The American Journal of Clinical Nutrition, vol.64 , 635-639, 1996
A. Agil Abdalla "Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM",  Diabetes Care, vol.18 , 646-653, 1995
M.D.B. Ocaña Ocaña, E. Del Pozo Gavilán, M. Barrios García and J.M. Baeyens Cabrera,  "SUBGROUPS AMONG MU-OPIOID RECEPTOR AGONISTS DISTINGUISHED BY ATP-SENSITIVE K+ CHANNEL-ACTING DRUGS",  BRITISH JOURNAL OF PHARMACOLOGY , vol.114 , 1296-1302, 1995
M.D.B. Ocaña-Ocaña, E. Del Pozo-Gavilán, M. Barrios-García and J.M. Baeyens Cabrera,  "SUBGROUPS AMONG MU-OPIOID RECEPTOR AGONISTS DISTINGUISHED BY ATP-SENSITIVE K+ CHANNEL-ACTING DRUGS",  British Journal of Pharmacology, vol.114 , 1296-1302, 1995
A. Agil Abdalla "Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction",  Clinical Chemistry, vol.41 , 220-225, 1995
M. Barrios García and J.M. Baeyens Cabrera,  "ATP-SENSITIVE K+ CHANNEL OPENERS INHIBIT MORPHINE-WITHDRAWAL",  EUROPEAN JOURNAL OF PHARMACOLOGY, vol.251 , 113-115, 1994
M. Barrios García and J.M. Baeyens Cabrera,  "ROLE OF L-TYPE CALCIUM CHANNELS ON YOHIMBINE-PRECIPITATED CLONIDINE WITHDRAWAL IN-VIVO AND IN-VITRO",  ARCHIVES PHARMACOLOGY, vol.348 , 601-607, 1993
A. Agil Abdalla,  "Estudios farmacognósticos sobre ecballium elaterium (l. )a. Richard. ", 1991

Última actualización del SICA: 30/04/2025

Desarrollado por: